Strikingly, when dividing an NSCLC dataset (GSE31852) by KRAS-mutation status, FSP1 expression was significantly upregulated in KRAS-mutated patient material (Fig. 6b). This evidence concerns the gene KRAS and non-small cell lung carcinoma.